TSANZ home

Results for "spirometry"

Home 5 Search query for: spirometry
Results for "spirometry"

When Infection Control Meets Work Health and Safety – Learnings From Victoria during COVID-19

When Infection Control Meets Work Health and Safety – Learnings From Victoria during COVID-19

Date Recorded: 4th December 2020

Time: Approx. 1.5hrs

This webinar aims to understand and learn from the experiences of working in a COVID-positive clinical environment, in particular focusing on the impacts of the Victorian experience of COVID-19 and focus on the things done, the learnings, and the unresolved issues within the WHS space. Come join us for presentations and a panel discussion from our expert group!

Prof Bruce Thompson (Chair) – TSANZ President

Dr Nick Coatsworth – Federal Deputy CMO
Dr Nick Coatsworth is one of Australia’s Deputy Chief Medical Officers. He is also the Executive Director of the Medical Services Group at Canberra Health Services. Nick held a key national role in the Australian response to COVID-19. Bringing together his skills as an infectious disease physician, a respiratory physician, a practitioner of disaster and humanitarian medicine, and high-level experience in health administration, Nick’s contribution provided a voice for frontline hospital staff in the national response to the pandemic. He became one of the most recognised medical spokespeople during the pandemic, engaging the Australian community through a variety of media platforms.

A/Prof Lou Irving – The Royal Melbourne Hospital
Lou Irving is Director of Respiratory and Sleep Medicine at Royal Melbourne Hospital and Director of the Lung Tumour Stream at Peter MacCallum Cancer Centre. He has been involved in clinical research over many years and has published over 230 articles.

Ms Brigitte Borg – The Alfred
Brigitte Borg is an accredited clinical physiologist (respiratory) with 27 years’ experience. Brigitte works at The Alfred, Melbourne as Head, Physiology Service, Respiratory Medicine. Brigitte’s areas of interest in the field of respiratory medicine include lung function interpretation (for which she co-authored a book in 2014), laboratory accreditation, quality spirometry in primary care, and oxygen therapy.

Dr Forbes McGain – Western Health, University of Sydney and University of Melbourne
Forbes is an anaesthetist and intensive care physician at Western Health, Melbourne, Australia, and an Associate Professor (Medicine) at the University of Sydney, and the University of Melbourne.

He enjoys being involved in research, teaching and education at the hospital, university and beyond. In 2020, during the COVID-19 pandemic, Forbes and mechanical engineers at the University of Melbourne collaboratively produced a personal isolation hood to reduce SARS-CoV-2 transmission to healthcare workers. Forbes also remains passionate about making seemingly small environmental sustainability changes to how we practice medicine that become magnified through every nations’ hospitals.

Ms Ceri Banks – Peninsula Health
Ceri Banks is a Clinical Research Nurse Consultant at Peninsula Health in Melbourne. She is the coordinator of respiratory clinical trials and a Severe Asthma Clinic, managing patients undergoing bronchial thermoplasty and monoclonal therapy. She is a presenter for the National Asthma Council and co-convenor of the TSANZ Respiratory Nurses Group.

Registration:

To register your interest in the on-demand recording, please register below. You will then be sent an e-mail, allowing you to obtain the recording links through Vimeo.

Category Fee (excl. GST)
TSANZ Members Free
Non-members $20.00

Require assistance?

Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

VOLUME 5.04 – JUNE 2020

VOLUME 5.04 – JUNE 2020

Research Roundup:

June 2020

 

Welcome Message

Welcome to this exciting update of the Research Roundup.

Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the June edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

2020 Respiratory Research Excellence Awards

 

TSANZ congratulates the following award winners!!!

 

Ann Woolcock New Investigator Award Winner: Kurtis Budden

Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

Janet Elder International Mid-Career Travel Award: David G Chapman

Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

 

TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

2020 TSANZ Awards by Nomination

At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

TSANZ Society Medal – Associate Professor Tara Mackenzie

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

Fellowships

  • Professor Richard Beasley
  • Professor Margaret Wilsher
  • Professor Ross Vlahos

Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

Congratulations to all!

Respirology – Editor’s Choice 

Respirology Issue 25.5 May 2020

 

Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

 

Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

DOI: 10.1111/resp.13744

 

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

 

Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

DOI: 10.1111/resp.13682

Respirology Issue 25.6 June 2020

 

Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

 

A collection of e-cigarettes and e-liquids for sale to vapers

DOI: 10.1111/resp.13696

 

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

 

 

The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

DOI: 10.1111/resp.13753

TSANZSRS 2020 Abstracts

Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

 

Invitations and surveys

 

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

.

 

VOLUME 5.04 – JUNE 2020

VOLUME 5.02 – MARCH 2020

Research Roundup:

March 2020

.

Welcome Message

By now I’m sure you’ve heard that TSANZSRS 2020 has been postponed until 29 April – 4 May 2021. The TSANZ Board released a letter and FAQ outlining this decision on 12 March 2020.

The Board is busy working through all the issues that have arisen from this decision and we will be in touch with updates as they happen. Whilst the the Research Sub-Committee has finalised most awards, we are now looking at how to publicly acknowledge 2020 award recipients. 

COVID-19

Infectious diseases research is a significant area of strength in Australia and the TSANZ acknowledges the important work of our Australian researchers who are international leaders in research surrounding COVID-19. Examples include the creation of the vaccine candidate for COVID-19 by the University of Queensland – achieved in just three weeks! Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne have already begun small-scale testing. Doherty Institute researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection (published in Nature) while CSIRO’s research aims to get a better understanding of the virus – how long it takes to develop and replicate, how it impacts the respiratory system and how it can be transmitted. 

We also acknowledge the support of the Australian Government that will invest $30 million for COVID-19 research to enable Australian researchers to contribute to global efforts to control the outbreak. In addition, NHMRC recognises that the COVID-19 pandemic may be affecting the research of current grant holders. If you have received a grant and circumstances have changed – for example, there has been a delay in your Research Activity because of involvement in the clinical or public health response – you can apply to vary your grant. Variations that may be relevant due to the impact of COVID-19 include: Deferral of commencement date and requests for grants applications, deferral of an in-progress grant and extended leave requests, extended end date, change to a research plan or change to chief investigators. For more information please visit: https://www.nhmrc.gov.au/funding/manage-your-funding/vary-your-grant.

TSANZ are collaborating to support the Australian Living Evidence Consortium who, with Cochrane Australia are working to develop a National COVID-19 Clinical Evidence Taskforce. There is a survey below which will help to determine high-priority clinical questions and a request for EOIs to join the guideline panel. I encourage all interested parties to contribute to this work through the article below.

We wish you all the best in your work and in preparation of your grant applications.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

National COVID-19 Clinical Evidence Taskforce

Dear colleague,

The Australian Living Evidence Consortium and Cochrane Australia are working with others to support the development of a National COVID-19 Clinical Evidence Taskforce. As part of this we are working with peak professional bodies to develop living, evidence-informed guidance for primary, hospital and critical care of adults and children with suspected or confirmed COVID-19 infection. Guidance will be updated weekly as new evidence emerges.

We would like your suggestions for high-priority clinical questions to be addressed by this guidance.

Please suggest questions by completing the form at https://forms.gle/SDS9t2tMhiHvnRoPA by 9pm Sunday March 22.

We are also seeking interested clinicians to join guideline panels. These will initially be convened next week, and then meet regularly over the next weeks and months to review emerging evidence and refine the recommendations. To express your interest in membership in a guideline panel, please email your CV to Dr Britta Tendal, Senior Research Fellow at Cochrane Australia at britta.tendal@monash.edu by 9pm Sunday March 22. 

If you have any queries please contact Dr Tari Turner, Senior Research Fellow at Cochrane Australia at tari.turner@monash.edu

Thank you

Respirology – Editor’s Choice 

Respirology Issue 25.3 March 2020

 

Global Lung Function Initiative‐2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults

Tamara L. Blake, Anne B. Chang, Mark D. Chatfield, Julie M. Marchant and Margaret S. McElrea

 

DOI: 10.1111/resp.13649

Study participant from Thursday Island performing spirometry (with permission by the Queensland Government)

 

Association of serious adverse events with Cheyne–Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis

Faizan Javed, Renaud Tamisier, Jean-Louis Pepin, Martin R. Cowie, Karl Wegscheider, Christiane Angermann, Marie-Pia D’ortho, Erland Erdmann, Anita K. Simonds, Virend K. Somers, Helmut Teschler, Patrick Levy, Jeff Armitstead and Holger Woehrle

 

 Schematic representation of CheyneStokes respiration signal.

DOI: 10.1111/resp.13613

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 5.04 – JUNE 2020

VOLUME 4.06 AUGUST 2019

Research Roundup:

August 2019

.
 

Welcome Message

We received some exciting news with the announcement that the National Dust Disease Taskforce has been established by the Australian Government Department of Health. TSANZ and its members will play a key role in the Taskforce, enabling us to further contribute to the work we have been doing around preventable occupational lung disease.

Don’t forget to visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards, and keep in mind the closing date of October 11th. Our Open Awards section below highlights our ongoing awards, grants and scholarships from the Lung Foundation Australia.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. Details can be found here. Our most recent submission by Dr Jane Bourke is featured in this month’s the limbic section below.

We hope you enjoy the August edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 24.8 August 2019

Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis

Hironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhasi, Dai Hashimoto, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda

Researchers from Hamamatsu University School of Medicine, Hamamatsu, Japan. From left to right: Prof. Takafumi Suda and Dr. Hironao Hozumi

DOI: 10.1111/resp.13506

 

Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions

Jose M. Porcel, Aureli Esquerda, Silvia Biesla, Anna Novell, Maria Alba Sorolla, Sonia Gatius, Carlos Zamora, Silvia Vidal, Antonieta Salud

 

The pleural research team at IRBLleida in Spain. From left to right: Drs Sorolla, Salud, Bielsa, Novell, Esquerda (behind) and Porcel.

DOI: 10.1111/resp.13539

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.09 DECEMBER 2018

Research Roundup:

December 2018

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have two awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS19!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 14 Feb 19

TSANZ Indigenous Respiratory Nursing Award – closes 31 Jan 19

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 23.12 (December 2018)

Inflammation-dependent and independent airway remodelling in asthma

John G. Elliot, Peter B. Noble, Thais Mauad, Tony R. Bai, Michael J. Abramson, Karen O. McKay, Francis H.Y. Green, Alan L. James

DOI: 10.1111/resp.13360

 

1000-fold magnification of the airway smooth muscle layer with a counting grid overlay for planimetry assessment of the airway smooth muscle area.

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

Canan Gündüz, Ozen K. Basoglu, Jan Hedner, Ding Zou, Maria R. Bonsignore, Holger Hein, Richard Staats, Athanasia Pataka, Ferran Barbe, Pavel Sliwinski, Brian D. Kent, Jean Lois Pepin, ​​​​​​​Ludger Grote, on behalf of the European Sleep Apnea Database Collaborators.

DOI: 10.1111/resp.13372

 

ESADA researchers and collaborators from left to right: Holger Hein, Sven Svedmyr, Ding Zou, Canan Gündüz, Ludger Grote.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.05 AUGUST 2018

Research Roundup:

August 2018

.
 

Welcome Message

 

It is a busy time of year for research administration. Last week we were both in Canberra and were very fortunate to meet with Professor Anne Kelso, NHMRC CEO. We had a very useful discussion with Anne on the lack of research funding achieved by respiratory health in comparison to the massive respiratory burden of disease and we discussed ways to improve this situation. Anne highlighted to us that the success rate of respiratory disease grants was 20.8%, which is well above the national average of 16.2% funding success. This means we have an extremely high quality respiratory workforce conducting research, we just don’t have enough grants being submitted. We all need to work to build workforce capacity. TSANZ will continue to advocate for increased respiratory research funds to support research positions as well as continuing to work with sponsors and donors to fund pilot research and pursue fellowship partnerships. At a local and group level we need each other to support and mentor early and mid-career researchers. Furthermore, in the future the NHMRC Ideas Scheme will award innovation and feasible ideas without weighting track record. These will be a great opportunity for our junior investigators.

The NHMRC grant structure is changing next year and grant review panels will not exist as we know them. Grants will be triaged into top grants (auto-fund), borderline grants, and grants not for further consideration. Grants which are borderline will then be reviewed by a few experts to determine their fundability. It is important that respiratory researchers from varied backgrounds continue to make themselves available to review national grants to ensure appropriate expertise is available. It is important that respiratory experts are reviewing respiratory grants as we best understand their potential impact. Please answer the call to participate on research panels. In doing so you ensure respiratory grants are reviewed by well qualified reviewers.

It is heartening to know that respiratory researchers are some of the most successful in the country. Let’s continue to build our respiratory community so that we can receive the support we need to find the cure and breath easy.

To that end we are pleased to announce our first awards are now open!

A suite of project grants are out to support pilot research into paediatric health, indigenous health, and alpha-1 deficiency. We are also grateful to be again hosting awards with the National Asthma Council Australia and Lung Foundation Australia. Please look below in the open awards article for more information.

Awards linked to abstracts opened with submissions to the TSANZSRS19 and these include the Janet Elder International Travel Award, the Ann Woolcock New Investigator, The Japanese Respiratory Society Travel Award, and the ASM Travel Awards. Please submit your abstract, apply for a travel grant (for ECRs) and join us on the Gold Coast in 2019. Furthermore, our ASM is preceded by the Asian Pacific Congress on Bronchology and Interventional Pulmonology and well worth the extended trip to Queensland.

Enjoy the August edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Lung Foundation Australia Awards

Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research 2018 – closes 21 Sep 18

Lung Foundation Australia / Ivan Cash Research Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research 2019 – closes 21 Sep 18

Lung Foundation Australia / Lizotte Family Research Award for Interstitial Pulmonary Fibrosis Research 2019 – closes 21 Sep 18

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Calling Australian and New Zealand Alpha 1 Researchers: The Alpha-1 Foundation is pleased to announce its funding opportunities for the 2018-19 grants cycle.

 

You can help bring the cure within reach!

Log onto www.alpha1.org for more information about our research opportunities, application deadlines and application instructions for the 2018-19 grants cycle. These grants are open to Australian and New Zealand researchers and you are strongly urged to apply.

2018-19 In-cycle letters of intent (LOI) are due by September 28, 2018 using the Alpha-1 Foundation’s online LOI form on ProposalCentral:

https://proposalcentral.altum.com/grantopportunities.asp?GMID=135

For Researchers interested in drug development funding, please visit The Alpha-1 Project’s (TAP) website at: http://www.thealpha-1project.com/ 

Please feel free to email with any questions – Email:  edgloria@alpha1.org

 

Respirology – Editor’s Choice

Respirology Issue 23.8 (August 2018)

Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand

Sean R. Blackall, Jae B. Hong, Paul King, Conroy Wong, Lloyd Einsiedel, Marc G.W. Rémond, Cindy Woods, Graeme P. Maguire

DOI: 10.1111/resp.13280

 

Spirometry in central Australia – bronchiectasis disproportionately impacts indigenous populations

 

Childhood measles contributes to post-bronchodilator airflow obstruction in middle-aged adults: A cohort study

Jennifer L. Perret, Melanie C. Matheson, Lyle C. Gurrin, David P. Johns, John A. Burgess, Bruce R. Thompson, Adrian J. Lowe, James Markos, Stephen S. Morrison, Christine F. McDonald, Richard Wood‐Baker, Cecilie Svanes, Paul S. Thomas, John L. Hopper, Graham G. Giles, Michael J. Abramson, E. Haydn Walters, Shyamali C. Dharmage

DOI: 10.1111/resp.13297

 

The population-based Tasmanian Longitudinal Health Study (TAHS) cohort provided the data for this study.

 

Research Project and Survey Requests

Community and patients on their experiences with spirometry

The European Lung Foundation, in partnership with the American Thoracic Society and European Respiratory Society Spirometry Task Force, is seeking input from community and patients on their experiences with spirometry.

We would greatly appreciate it if you can promote this survey through your organisational, community and social networks. The survey will be open until the 21st September 2018.

The survey is available in a number of languages and can be accessed directly through the link below or via the ELF news item also below.

If there are any specific questions please contact Courtney Coleman from the ELF.

The survey is available in Dutch, English, French, German, Greek, Italian, Polish, Portuguese, Russian and Spanish. Participants can select their language from the drop down menu at the top right of the survey.

The news item is available in English, French, German, Greek, Italian, Polish, Portuguese, Russian and Spanish by selecting the country flag at the top left of the website

Sent on behalf of the European Lung Foundation, in partnership with the American Thoracic Society and European Respiratory Society Spirometry Task Force.

 

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.04 JULY 2018

Research Roundup:

July 2018

.
 

Welcome Message

 

We want to share with you some good news for Respirology – the 2017 impact factors have been announced and Respirology’s impact factor has increased to 4.4 (from 3.25 in 2016). The journal’s ranking among the Respiratory System journals has also increased to 10/59(from 18/59 in 2016). The Research Roundup has been featuring the Respirology Editors Choice for one year now. We would like to Congratulate the team and thank past editor Peter Eastwood and current editors Phil Bardin and Paul Reynolds on this impressive growth in citations. We look forward to your future publications!

Now to awards – a number of grants-in-aid and travel awards are closing soon. The Lung Foundation Australia have also just opened up two new memorial awards for Interstitial Lung Disease. Please look to the open awards below so that you do not miss out.

We would like to highlight the next endeavour from Bill van Nierop who is launching his second Lung campaign – Long Kayak for Lungs. This campaign aims to raise awareness and understanding of lung diseases within the community, remove the stigma often linked to those with a lung disease, help change community attitudes to this insidious disease group and raise some much needed funds on route. Bill attended our TSANZSRS18 to present a PhD scholarship which is supported through funds he raised in his last campaign. See the story of Bill’s next adventure below.

Enjoy the July edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

TSANZ NZ Branch ASM Travel Grant – closes 14 Jul 18

Lung Foundation Australia / Eleanor Greenwood Memorial Interstitial Lung Disease Travel Grant 2018 – closes 3 Aug 18

Lung Foundation Australia / Eleanor Greenwood Memorial Grant-in-Aid for Interstitial Lung Disease 2018/19 closes 3 Aug 18

Vertex Cystic Fibrosis Research Awards – NACFC closes 08 Aug 18

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards – (APSR) extended to 17th Aug Jul 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

 

Long Kayak for Lungs

Following on from the successful Long walk for Lungs last year , Bill Van Nierop has raised the bar in his ongoing endeavours  in supporting  Lung Foundation Australia with their  efforts in research and patient support with a remarkable new challenge for 2018, The Long Kayak for Lungs, 42 Days/2,200 Km’s Albury NSW to the Murray Mouth in South Aust.

This 2,200 km initiative is all about furthering the awareness and understanding of lung diseases within the community, remove the stigma often linked to those with a lung disease, help change community attitudes to this insidious disease group and raise some much needed funds on route.

Funds raised via the Long Walk for Lungs were used to initiate a PHD Scholarship in Idiopathic Pulmonary Fibrosis Research, support for Lung Foundation Patient Support groups, and contribute to the funding for a future respiratory nurse to support patients across Australia.

Bill is determined to paddle the distance and raise vital research funding to support Australians living with lung diseases like IPF.

​Bill lives in Brisbane, working for AGnVET Services. Bill is married to Lesley with 3 children and 5 grand kids, who Bill would like to be around to see grow up.

Support Bill’s efforts at www.longkayakforlungs.com.au and follow his journey.

FLYER

_____________________________________________________________________________

Lung Foundation Cycle Challenge 

The Thoracic Society of Australia and New Zealand (TSANZ) is raising much needed funds for Lung Foundation Australia by participating in The Corporate Cycle Challenge 2018. On Friday 3rd August, TSANZ Staff will participate in this challenge to support the work of the Lung Foundation Australia.

TSANZ is the only health peak body representing a range of professions (medical specialists, scientists, researchers, academics, nurses, physiotherapists, students and others) across various disciplines within the respiratory/sleep medicine field in Australia and New Zealand.

TSANZ is committed to serving the professional needs of its members by improving knowledge and understanding of lung disease, with the ultimate goals being to prevent respiratory illness through research and health promotion and to improve health care for people with respiratory illness.

You can help, too! Please CLICK HERE to donate or if you are interested in joining the challenge.

Any amount you can give makes a difference. Thank you for your generosity and support!

Respirology – Editor’s Choice

Respirology Issue 23.7 (July 2018)

Segmentectomy versus Lobectomy in Early Non-Small Cell Lung Cancer of 2 cm or less in Size: A Population-Based Study

MI HYOUNG MOON, YOUNG KYU MOON and SEOK WHAN MOON
DOI: 10.1111/resp.13277

 

Research team from the Catholic University of Korea in Seoul. From left to right: Drs Young Kyu Moon, Mi Hyoung Moon and Seok Whan Moon.

 

Ethnic differences in lung function in China: results from a large community-based epidemiological study

RUOHUA YAN, LAP AH TSE, ZHIGUANG LIU, JIAN BO, EMILY Y. CHAN, YANG WANG,
LU YIN,WEI LI on behalf of PURE-China Investigators
DOI: 10.1111/resp.13258

 

Research team from the National Center for Cardiovascular Diseases and the Chinese University of Hong Kong, China. Left to right: Jian Bo (inset), Zhiguang Liu, Ruohua Yan, Lu Yin, Wei Li, Lap Ah Tse, Emily Y. Chan and Yang Wang.

 

Research Project and Survey Requests

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.03 JUNE 2018

Research Roundup:

June 2018

.
 

Welcome Message

We are deep in conference season with both the TSANZSRS18 and the ATS Congress now finished for another year. At TSANZSRS18, respiratory research received a much needed boost of over $2 million funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and we hope you enjoyed this new -look celebration. You can recap the TSANZ research winners on our website. ATS Congress was another huge event and we invite you to look at the limbic stories below for highlights. The next international meeting in the respiratory circuit is the ERS Congress in Paris Sept 15-19. There are ERS travel awards available still so please look into these if you are planning on attending. 

We would also like to highlight the funding opportunities available for those researching alpha-one antitrypsin deficiency in lung disease. There are large grants on offer from the Alpha One Association and these do not require any specific membership and international collaborations for eligibility.

Furthermore, the Thoracic Society Research Medal and other awards by nominations are now open. Please consider nominating a member in recognition of their outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand.

Finally, I encourage you all to complete the survey at the end of this newsletter in regards to The Global Lung Function Initiative (GLI). The GLI has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations. They are now seeking feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation.

Enjoy the June edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

TSANZ NZ Branch ASM Travel Grant – closing 14 Jul 18

Vertex Cystic Fibrosis Research Awards – NACFC closing 08 Aug 18

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards – ERS closing 29 Jun 18, APSR closing 09 Jul 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Support TSANZ

This year, TSANZ is asking members to provide a tax deductible donation to support our work in respiratory research and/or clinical care. You can choose to donate to one, or both, of the programs detailed below:

1. TSANZ 50th Anniversary Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor. In 2018, this program supported the development of two clinical programs:

  • Take the Bronchiectasis Toolbox on the road: A program aiming to build upon the tremendous work of the Bronchiectasis Toolbox by increasing its effectiveness in in Australia’s regional and remote areas. TBTR is designed to bridge the gap between electronic platform and clinician by supplementing the Toolbox’s online content with face-to-face educational workshops, as well as further online resources and telephone and email support.
  • A clinician’s guide to early diagnosis of PCD – when common symptoms mean so much more!: An online educational resource for medical staff to aid in the early and accurate diagnosis of Primary Ciliary Dyskinesia (PCD). This resource aims to increase medical awareness of suggestive symptoms as well as referral directions for diagnostic testing. This guide will not only better enable clinicians to identify PCD in its crucial early stages, but provide them with the knowledge of specific PCD therapy aims that they need to ensure their patients receive the best treatment possible.

 – CLICK HERE to make a donation.

2. Joint TSANZ/LFA Research Program

In 2018 were able to recognise three respiratory health researchers for their work in combating serious lung disease. The 2018 Lungs for Life Research Award winners were:

Professor Phil Hansbro: Cell free microRNA: potential biomarkers for the early detection of lung cancer

Dr Malcolm Starkey: Understanding how group 2 innate lymphoid cells in early-life regulate postnatal lung development and susceptibility to chronic lung diseases

Dr Megan Jensen: Maternal and Early Life Vitamin D exposure and asthma risk in high risk infants

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease. Please CLICK HERE to make a donation.

3. Leave TSANZ a gift in your will – If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy. If interested, please notify us by ticking the box on the Support TSANZ form attached. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

4. TSANZ New Zealand Branch IncorporatedCLICK HERE to make a donation.

New Zealand members are able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.

TSANZ Medals  

We apologise for the mistake we made in our latest article on the Society Medal in the May e-news. In response, we would like to congratulate the recipients of three prestigious TSANZ Medals: the Society Medal, the Research Medal, and the 50th Anniversary Medal. These awards are presented to TSANZ members as an acknowledgement of their outstanding contributions to respiratory health in research, education, and the health sector.

Nominations for the year have now opened! If you wish to nominate an extraordinary TSANZ member for their work in respiratory health, please visit https://www.thoracic.org.au/researchawards/tsanz-awards-by-nomination for more information.

Previous recipients of these prestigious TSANZ Medals are listed below:

The Research Medal

1992 Professor Ludwig Engel (posthumously) 
1994 Professor Colin Sullivan
1996
Professor Terry Nicholas
Professor Peter Phelan
1998 Professor Judith Black
1999 A/Professor Philip Thompson
2000 Professor Richard Beasley
2003 A/Professor Peter Gibson
2005 Professor Peter Sly
2006 A/Professor Gary Anderson
2007 Professor Haydn Walters
2008 Professor Bruce Robinson
2009 Professor Peter Bye
2010
Professor Guy Marks
2011
Professor Bill Musk
Professor Michael Abramson
2012 A/Professor Paul Forrest
2013 Professor Anne Chang
2014 Professor Scott Bell
2015 Professor Richard Beasley
2016 Professor Ron Grunstein
2018 Professor Peter Le Souef

 

 

The Society Medal

1992 Dr Maurice Joseph
1993 Dr Roy Mills
1994 Professor Tom O’Donnell
1995 Dr Michael Pain
1996 Dr Alastair Campbell (posthumously)
1997 Dr Michael Burns
1998 Professor Ann Woolcock
1999 Dr Kevin Finucane
2002 Dr Peter Rothwell
2004 Dr Abraham Rubinfeld
2006 A/Professor Charles Mitchell
2008 Dr Bob Edwards
2011 Judge John O’Meally
2012 Professor Norbert Berend
2013 Professor Philip Thompson
2014 Professor Peter van Asperen
2015 Professor Martin Phillips
2016 Professor Iven Young
2017 Professor Peter Holmes
2018 Professor Paul Reynolds

 

50th Anniversary Medal

2011 Dr Paul Zimmerman 
2012
A/Professor Tara Mackenzie 
2013 Professor Fiona Lake
2014 A/Professor Chien-Li Holmes-Liew 
2015 Professor Hubertus Jersmann
Dr Nicholas Saltos
2016 Professor Peter Frith
2017 Professor Jennifer Alison
Professor Richard Ruffin

 

Respirology Issue – Editor’s Choice

Vitamin D and respiratory health in the Busselton Healthy Ageing Study

SIOBHAIN MULRENNAN, MATTHEW KNUIMAN, JOHN P. WALSH, JENNIE HUI, MICHAEL HUNTER, MARK DIVITINI, KUN ZHU, BRIAN R. COOKE, ARTHUR W. (BILL) MUSK and ALAN JAMES

DOI: 10.1111/resp.13239

 

A Busselton Health Study participant undergoing lung function testing

 

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

JOSEPH JACOB, BRIAN J. BARTHOLMAI, SRINIVASAN RAJAGOPALAN, RONALD KARWOSKI, ARJUN NAIR, SIMON L.F. WALSH, JOSEPH BARNETT, GARY CROSS, EOIN P. JUDGE, MARIA KOKOSI, ELISABETTA RENZONI, TOBY M. MAHER and ATHOL U. WELLS

DOI: 10.1111/resp.13231

 

The Royal Brompton Hospital in South Kensington, London, UK (left), and the Mayo Clinic in Rochester,  MN, USA  (right).

 

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

JUNYA OKUMURA, YUICHIRO SHINDO, KUNIHIKO TAKAHASHI, MASAHIRO SANO, YASUTERU SUGINO, TETSUYA YAGI, HIROYUKI TANIGUCHI, HIDEO SAKA, SHIGEYUKI MATSUI, YOSHINORI HASEGAWA on behalf of the Central Japan Lung Study Group

DOI: 10.1111/resp.13232

 

The Nagoya University Respiratory Tract Infection Team studied approximately 1500 patients with pneumonia from 10 different hospitals on behalf of the Central Japan Lung Study Group.

 

Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease 

LASZLO T. VASZAR, BRANDON T. LARSEN, KAREN L. SWANSON, JAY H. RYU AND HENRY D. TAZELAAR

DOI: 10.1111/resp.13223

 

The research team from the Mayo Clinics in Scottsdale, AR, and Rochester, MN, USA, from left to right: Karen L Swanson, Henry D Tazelaar, Laszlo T Vaszar, Brandon T Larsen and Jay H Ryu (inset top right).

 

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

STEVEN MCKINSTRY, JANINE PILCHER, GEORGE BARDSLEY, JAMES BERRY, SUSANNE VAN DE HEI, IRENE BRAITHWAITE, JAMES FINGLETON, MARK WEATHERALL and RICHARD BEASLEY

DOI: 10.1111/resp.13185

 

Nasal High Flow therapy in action

 

Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheter

HISASHI TSUKADA, PLAMENA ENTCHEVA-DIMITROV, ARMIN ERNST, SAMAAN RAFEQ, JOHN H. KEATING, KIRK P. SEWARD and LONNY YARMUS

DOI: 10.1111/resp.13214

 

The Blowfish® Transbronchial Micro-Infusion Catheter

 

Research Project and Survey Requests

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.01 FEBRUARY 2018

Research Roundup:

February 2018

.
 

Welcome Message

Welcome to the first Research Roundup of 2018. The Research Subcommittee are currently working their way through reviewing the many award applications received in the last couple of months. This year, for the first time and together with Lung Foundation Australia and Cystic Fibrosis Australia, we will be awarding $1 million worth of research funding at the TSANZSRS in Adelaide. We thank our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge with the goal to prevent, cure and relieve disability from lung disease.

The ASM is the flagship event of the year where our Society comes together, and this is also a good time for us to share our research stories. We would like to invite all members who have a research story; from an idea to an outcome, to share with this us. This story will be developed further at the ASM with our media partners and help to showcase our research talent and leverage our research profile. Please see the Tell Your Story article within this newsletter for more information.

We are proud to advise that the TSANZ Board has endorsed our first ever Research Strategy. This strategy outlines what we support: research projects, career development, advocacy driven research, and indigenous health, and how we do this: through direct-to-researcher funding, partnerships, and providing infrastructure. This strategy is underpinned by good governance and upholding equity and diversity across our robust and independent research administration.

We wish you all the best in your work and in preparation of your grants.

Enjoy the February edition of your research roundup.

Prof Phil Hansbro

Prof Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Maurice Blackburn ASM Travel Award 2018

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the TSANZ Annual Scientific Meeting (ASM) through presentation of their work and active participation in the meeting. There will be one award of AUD 1500 to support the career development of TSANZ nurses, physiotherapists and other allied health professionals who do not already receive travel support from their institution.

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Tell Your Story

During 2017, the Research Subcommittee drafted the TSANZ Research Strategy and this was endorsed at the last TSANZ Board meeting of 2017.

This strategy outlines what we support:

  • Research projects
  • Career development
  • Advocacy driven research, and
  • Indigenous health

We do this through direct-to-researcher funding, partnerships, and providing infrastructure. This strategy is underpinned by good governance and upholding equity and diversity across our robust and independent research administration. 

Whilst things are improving, and now we even have the Cardiorespiratory Field of Research, there is still a way to go in promoting Respiratory Research.

We would like to showcase our member’s research stories. If you have a story about an idea or an observation which you have followed through and been able to deliver outcomes on, we would like to know about it.

Telling these stories to the general public, government, and industry, will help to raise the profile of respiratory research and peoples desire to support it.

Respirology Issue 23.2 – Editor’s Choice

Non-invasive ventilation during cycle exercise training in patients with chronic respiratory failure on long-term ventilatory support: A randomized controlled trial

MICHELE VITACCA, DICLE KAYMAZ, BARBARA LANINI, GUIDO VAGHEGGINI, PINAR ERGÜN, FRANCESCO GIGLIOTTI, NICOLINO AMBROSINO AND MARA PANERONI

DOI: 10.1111/resp.13181

 

The respiratory division team at the main centre of the international collaborative research project in Lumezzane, Italia, including authors Michele Vitacca and Mara Paneroni (first and second person from the right side).

 

Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure

DONGXING ZHAO, YUMIN ZHOU, CHANGBIN JIANG, ZHUXIANG ZHAO, FANG HE AND PIXIN RAN

DOI: 10.1111/resp.13176

 

The First Affiliated Hospital of the Guangzhou Medical University on the river bank of the Pearl river in Guangzhou, China, where the research study was performed. 

Research Project and Survey Requests

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

 

‘Usual’ antenatal asthma management

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma managementconsists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study (NSW HREC Reference No: HREC/16/HNE/394).  All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

Thank you,

Dr Vanessa Murphy, Vanessa.Murphy@newcastle.edu.au
Ms Karen McLaughlin, Karen.McLaughlin@hnehealth.nsw.gov.au 

.

VOLUME 5.04 – JUNE 2020

VOLUME 2.6 AUGUST 2017

Research Roundup:

August  2017

.
 

Welcome Message

Have you heard? Abstracts for TSANZSRS 2018 are now open. With this, our abstract-linked awards are also open. We are once again calling for applicants for the Ann Woolcock New Investigator Award, the JRS Travel Award, the Janet Elder Travel Award, and the Boehringer Ingelheim COPD Travel Award – which is now available to support travel to a range of international respiratory conferences (instead of only CHEST). Our ASM Travel awards are also open and we hope that everyone who is eligible takes up these opportunities.

More details on these awards are below and online.

Just over the horizon is APSR 2017 in Sydney.  A large number of abstracts have been received and late breaking abstracts will open on August 9th. Abstract acceptance will be notified in mid- August. If your abstract is accepted, you must be registered by September 28th. The developing program is now live. The theme is Lung Health in a Changing Worldand with a diverse and experienced group of international speakers attending, this should be a highly educational and engaging meeting. Early bird registration closes 3 September.

We have been able to partner with TEVA Pharmaceuticals and launch the TSANZ/TEVA Scholar Awards which cover registration costs for APSR 2017. These are open to Advanced Trainees in Respiratory and/or Sleep medicine and applications close on the 30th of August. Please spread the word – there are 30 scholarships available.

I would also like to update you on the consultation on A framework for NHMRC assessment and finding of clinical trials and cohort studies which we recently responded to. Thank you to those who assisted with this. Our response was in line with our commitment to increasing investment in respiratory research. While TSANZ was broadly supportive of the consultation recommendations, we advocated for inclusion of a policy review period, a moderation of process, opportunity to appeal and some consideration of a change in the length of the application given the necessity to include other supporting documentation for specific types of studies.

We will continue to work to increase funding for respiratory research and will adapt as the research landscape in Australia and New Zealand continues to change.

Lastly, there are a number of surveys at the end of this email and I urge you to participate in these and help where you can.

Enjoy the August edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

 

The following articles will take you to thelimbic.com

Work-related lung disease cases “tip of the iceberg”. A national register to record every case of work-related lung disease is one step closer following lobbying from the TSANZ and the Lung Foundation. Read More.

 + The rules for work-related lung disease compo are “unfair”. There are calls to expand the list of work-related lung disorders eligible for government compensation in NSW, amid concerns many with life-threatening conditions are missing out. Read More.

Oxygen saturation should be the 5th vital sign. A pulse oximeter should be as ubiquitous as a stethoscope, according to the British Thoracic Society’s new guidelines. Read More.

Non-invasive ventilation cuts COPD readmissions. Hard to treat patients with frequent COPD exacerbations can be kept out of hospital for longer when NIV is added to home oxygen. Read More.

Chronic breathlessness syndrome: a new name without shame.  We speak to Palliative medicine specialist Professor David Currow about his mission to get chronic breathlessness recognised as a distinct clinical entity. Read More.

Turf war stalling antibiotic stewardship. A rift between respiratory physicians and infectious diseases specialists could be stalling efforts to fight the growing problem of antimicrobial resistance in patients with respiratory infections, researchers claim. Read More.

Better bedside management of pleural effusions. Brisbane doctors have significantly improved the outcomes of patients with pleural effusions by giving registrars and trainees practical hands on training on the use of pleural ultrasound. Read More.

Open Awards

Thoracic Society Awards

TSANZ / TEVA Scholar Award

Encouraging all TSANZ Advanced Trainees Members to attend APSR 2017 for career development. Close 30 August 2017.

Abstract-linked awards are now open

Ann Woolcock New Investigator Award

The Ann Woolcock New Investigator Award is presented at the TSANZ Annual Scientific Meeting (ASM) to acknowledge excellence in the conduct and presentation of scientific research. 

This is a Travelling Fellowship of AUD$1500 plus expenses (return economy airfare, meeting registration and accommodation) to support the recipient to attend and present their original high-quality research to the next Annual Scientific Meeting of the Asia-Pacific Society of Respirology (APSR). Finalists (excluding the winning applicant) will receive a certificate of achievement and AUD $500.

This award furthers one of Professor Ann Woolcock’s goals of fostering research ties between the TSANZ and the APSR.

To apply for the Ann Woolcock New Investigator Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Ann Woolcock New Investigator Award eligibility criteria and application here coversheet please click here.

Boehringer Ingelheim COPD Travel Award

This travel award is designed to reward, encourage and provide international exposure for Advanced Trainees in Respiratory Medicine, junior Respiratory Physicians, post-doctoral respiratory healthcare professionals, and Respiratory Researchers whose work focuses on chronic obstructive pulmonary disease (COPD).

The award consists of up to AU$4000 to cover the recipient’s expenses (return airfare, registration, accommodation, living expenses) to attend and present an abstract at a relevant international respiratory conference, including: the American College of Chest Physicians, the European Respiratory Society, Asian Pacific Society of Respirology , or the American Thoracic Society.

To view the Boehringer Ingelheim COPD Travel Award eligibility criteria and application coversheet please click here.

Janet Elder International Travel Award

These awards will be made to three respiratory scientists or clinicians on the basis of scientific merit of their submitted abstract to the 2018 TSANZ Annual Scientific Meeting (ASM) to support their professional development in respiratory research. There will be two awards for early career researchers and one award for a mid-career researcher.

Each award consists of AUD$2500 to contribute to expenses to attend and present an abstract at an international scientific meeting of the recipient’s choice within the following year. 

These awards are made in the memory of Dr Janet Elder, one of the pioneers of respiratory medicine in Western Australia.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Janet Elder International Travel Award eligibility criteria and application coversheet please click here.

Japanese Respiratory Society (JRS) Early Career Development

This Early Career Development Award is designed to reward, encourage and provide international exposure to promising recent advanced trainees/higher degree graduates. 

The award will cover the recipient’s expenses (return economy airfare to Japan, registration, accommodation, living expenses) to attend and present at the Annual Scientific Meeting of the Japanese Respiratory Society in the following year. This award is fully provided by the Japanese Respiratory Society.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Japanese Respiratory Society (JRS) Early Career Development eligibility criteria and application coversheet please click here.

TSANZ Travel Grants to 2018 ASM

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the Annual Scientific Meeting (ASM) through presentation of their work and active participation in the meeting. They are awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields, based on the quality of the abstract submitted for presentation to the ASM.

To be eligible for the TSANZ Travel Grants to 2018 ASM Award, you must submit an accompanying form of certification (attach here) completed by your supervisor/head of department using the upload functionality in the online abstract submission form. To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the TSANZ Travel Grants to 2018 ASM eligibility criteria and application coversheet please click here.

Lung Foundation Australia Awards

Lung Foundation Australia and Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Research Fellowship – 2018/2019

Valued at $80,000 per year/ one or two years

Lung Foundation Australia / Boehringer Ingelheim COPD Fellowship supports research to improve the diagnosis and management of Chronic Obstructive Pulmonary Disease in Australia. Specifically, the proposed research must be aimed at developing and/or delivering optimal care to people with COPD.

Relevant domains of research inquiry range from evaluation of population screening initiatives; interventions to improve diagnostic accuracy within primary care; through to issues of management in the context of a clinician-patient interaction to system level issues to do with the organisation, financing and performance of the health system, including COPD management of indigenous and ethnic minorities within Australia.

Lung Foundation Australia invites applications from medical and scientific graduates who will be a resident in Australia throughout the period of the research program. The Fellowship is available as either a one or two year award, with a value of $A80,000 per annum. The funds are to cover the salary (including on-costs) for the successful research fellow and for no other purpose.

Apply now


NEW Lung Foundation Australia and the Better Breathing Foundation Allied Health PhD Scholarship in Chronic Lung Disease – 2018/2021

Valued at $20,000 per year/four years: $40,000 per year/four years with matched funds

This Scholarship is made possible via a collaborative partnership with Lung Foundation Australia and the Better Breathing Foundation. The LFA/BBF Allied Health PhD Scholarship aims to support allied health professionals to undertake research into chronic lung disease. Relevant domains of research include any form of clinical, population, laboratory or genetics research.

Students with an allied health background wishing to undertake a PhD in chronic lung disease are invited to submit an application. This PhD Scholarship is aimed at a researcher who is commencing a higher degree and interested in improving outcomes for patients living with a chronic lung disease.

Lung Foundation Australia/Better Breathing Foundation will be allocating a set amount of funds of $20,000 per year over a four year period (total funding: $80,000) for the PhD Scholarship, with matching funds to be provided by the University.

Apply now


Lung Foundation Australia / Ivan Cash Research Grant-in-Aid for Idiopathic Pulmonary Fibrosis Research 2018

Valued at $5,000

The Ivan Cash Research Grant-in-Aid’s creation was made possible by a bequest from Mr Ivan Cash, who sadly died from his idiopathic pulmonary fibrosis (IPF) in 2008. Lung Foundation Australia invites applications for the Ivan Cash Research Grant-in-Aid valued at $5,000. This IPF Research Award is open to any individual health care professional or scientist, who will be required to collaborate with the Australian IPF Registry management committee to undertake and publish a specific focused analysis of part of the collected dataset of the Australian IPF Registry. The Australian IPF Registry management committee will provide support to the successful applicant to enable the completion of the required research.

Apply now


Lung Foundation Australia / Lizotte Family Research Award for Interstitial Pulmonary Fibrosis Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Lizotte Family Research Award valued at $5,000 – to assist research in interstitial pulmonary fibrosis (IPF). This Research Award is open to any individual health care professional or group of health care professionals who are able to demonstrate an interest in IPF, including respiratory physicians, histopathologists, radiologists, researchers, registrars, trainees, nursing and allied health staff.

The funds may be used as a contribution towards IPF related research or pilot projects, or to fund travel or education with respect to increasing knowledge about IPF.

Apply now


Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Ludwig Engel Grant-in-Aid valued at $5,000 – to assist research in respiratory physiology. For the purpose of this Grant-in-Aid, Physiological Research is the use of any methodologies directed towards the elucidation of organ function and its understanding in a precise, quantitative manner.

The funds may be used as a contribution towards equipment, personnel or other running costs incurred in the conduct of research projects. The Grant-in-Aid is not to be used to fund conference travel or conference attendance.

Apply Now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to key health professionals in Australia whose work is focused on improving outcomes for patients living with COPD.

Apply now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

How to participate

Follow the links above to access each award application form and download the information sheet.

More Information

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Lung Foundation Australia contact details
Glenda Colburn | Phone 07 3251 3600 | Email: glenda@lungfoundation.com.au

Watch this space for more award announcements…

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late August and December, 2017:

Westpac Bicentennial Foundation Research Fellowship – closes 31/08/17
The Westpac Research Fellowship supports outstanding early career researchers whose ground-breaking work has the potential to make a difference in one of the Foundation’s focus areas: Technology and innovation, Strengthening Australia-Asia ties, and Enabling positive social change.

Westpac Bicentennial Foundation Social Change Fellowship – closes mid-August/2017
The Westpac Social Change Fellowship is an opportunity to invest in your capability, knowledge and networks with a view to helping you bring to life your innovative initiative for positive social change in Australia.

Rebecca L Cooper Medical Research Foundation – Medical Research Grants – closes 01/09/17
Advancing, promoting and encouraging medical research into Brain Sciences (psychiatry and neurology), Endocrinology and Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, Vision Sciences. Funding is primarily granted for the purchase of equipment, but may be used for other tangibles (e.g. therapeutic or imaging markers, software etc.). Funding requests for salaries/wages are not strongly supported, but will be considered by the directors.

The Prince Charles Hospital Foundation Emerging Researcher Grant – closes 01/09/17
The Emerging Researcher Grant is aimed at providing New Investigators who have previously received and successfully completed a New Investigator grant from TPCHF the opportunity to further develop their skills, experience and build the research capacity of TPCH The priority areas are: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Harkness Fellowships in Health Care Policy and Practice 2018-2019 – closes 05/09/17
For mid-career professionals (academic researchers, government policymakers, clinicians, managers, and journalists) from Australia, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom, to spend up to 12 months in the US conducting a policy-oriented research study, working with leading US health policy experts, and gaining an in-depth knowledge of the US and other health care systems.

Tasmania Community Fund – small grants close 06/09/17, large grants close 27/09/17
To fund community organisations that make a difference by enhancing well-being and improving the social, environmental and economic outcomes for the Tasmanian community. Five category areas: children and young people; community participation and recreation; community well-being and life skills; connecting communities; culture, arts and heritage. Large grants are for applications for large infrastructure, asset and/or equipment.

Future Research Leader Fellowships – EOI closes 15/09/17
5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to develop a program of work that support the activities that are being undertaken by the Translational Cancer Research Centres (TCRCs) in NSW. Applications must be in the area of implementation research and, more specifically, should address how research findings from the TCRCs can be taken up into routine cancer care.

CASS Medicine/Science Grants – 15/09/17
Research and development projects in science and/or medicine. Preference is given to proof of concept project applications. CASS will only accept applications from applicants employed by specific Victorian research centres.

Shepherd Foundation – closes 15/09/17
The Shepherd Foundation Trust welcomes grant applications from Victorian health professionals or research teams working in clinical, medical or scientific fields.  Grants are provided for research projects in all aspects of preventive medicine and/or occupational medicine. For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Conquer Cancer Career Development Award – closes 21/09/17
Provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Submissions in all oncology sub specialties are welcome.

Financial Markets Foundation for Children – closes 30/09/17
Research programs designed to improve the health, welfare and wellbeing of Australian children. Preference will be given to projects focussed on children aged 14 years and under, although the Foundation will consider projects relating to children up to 18 years of age.

Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/10/17
Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

World Cancer Research Fund International – closes 06/10/17
To fund research studies exploring the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival. There are 2 types of grants: Investigator Initiated Grants for Principal Investigators; and Pilot Grants to be used as start-up funds for pilot research. Two main themes: identifying the mechanisms that underpin the effects of diet, nutrition and physical activity on cancer; addressing the host factors that influence an individual’s susceptibility to cancer development or progression.

The Bonser Family Research Grant and Mi-tec Publishing Medical Research Grant – closes 21/10/17
Cancer Council Tasmania calling for research relating to the reduction of the incidence and impact of cancer on individuals and the community. It includes every aspect of care, from prevention and early detection that leads to a better outcome, treatment and supportive care. The priority area is cancer control.

Rolling Grants

Auswide Community Grants Scheme –  grants under $5 000 close 30/09/17, grants over $10 000 close 21/10/17, grants over$ 5 000 close 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

allport bequest – closes 30/06 and 31/12 yearly
Must benefit citizens of Hobart. Organisation must be charitable or the project must be for charitable purposes.

 

Respirology

New from ANZSRS

ANZSRS’s Spirometry Training Courses Position Statement
Maureen P. Swanney, Christopher A. O’Dea, Emily R. Ingram, Leanne T. Rodwell, Brigitte M. Borg, for the ANZSRS Spirometry Training Course Working Group

Respirology Issue 22.6

Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapores perspective on a global model.

HAI V. NGUYEN , SAIDEEP BOSE, SHWETA MITAL, ANTHONY CHAU ANG YII, SHIN YUH ANG, SEAN SHAO WEI LAM, DEVANAND ANANTHAM, ERIC FINKELSTEIN and MARIKO SIYUE KOH

DOI: 10.1111/resp.13027

 

Cost-effectiveness acceptability curve of bronchial thermoplasty with and without optimized asthma therapy

Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions

JONATHAN A. GALLI , ALOKNATH PANDYA, MICHELLE VEGA-OLIVO, CHANDRA DASS, HUAQING ZHAO and GERARD J. CRINER

DOI: 10.1111/resp.13024

Research team at the Temple Lung Center in Philadelphia, USA. From left to right: Huaqing Zhao, Jonathan Galli, Chandra Dass, Michelle Olivo-Vega and Gerard Criner.  Not included in the photo is Aloknath Pandya.

Research Project and Survey Requests

Inhaler Overhaul in Sight for Mild Asthma  –  recruitment closing soon

Friends and family with mild asthma could soon have a new treatment at their fingertips if results of the Novel Start Study show the condition can be well managed without daily medication.

People with apparently mild asthma make up 20 per cent of adults who die of asthma, and a third of people who need emergency asthma treatment,” says asthma specialist Professor Helen Reddel, who is heading the study in Australia.

Asthma experts in New Zealand and at the Woolcock Institute of Medical Research in Sydney and John Hunter Hospital in Newcastle are testing a new combination puffer treatment that could reduce asthma flare-ups and change the way mild asthma is treated worldwide.

Anyone who is using only Ventolin (or similar) for their asthma can volunteer – recruitment closes soon – by the end of August 2017.

Woolcock Institute, Sydney, Australia
Call: 02 9114 0444 or email gloria.foxley@sydney.edu.au

Hunter Medical Research Institute, Newcastle, Australia
Call: 02 4042 0532 or email joanne.howes@newcastle.edu.au

Medical Research Institute of NZ – Wellington, NZ
Call: 04 805 0147 or email irene.braithwaite@mrinz.ac.nz

 

 

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

ATS Conference Review

Please CLICK HERE to view the publication by Research Review on the recent American Thoracic Society (ATS) conference.

TSANZ Recruiting Now

Administrative Officer (up to $60,000 + super)

  • Excellent working conditions
  • Access to salary sacrifice and other benefits
  • Annual leave loading
  • Flexible working conditions, friendly team and great working environment

Function: This position is responsible for providing administrative support

Reports to: Chief Executive Officer (CEO)           

Salary: $50,000-$60,000 (dependent on experience)

Permanent full time

ROLE PURPOSE: This position is responsible for providing administrative support to the New Zealand Branch, assisting the CEO in managing the activities of the office and supporting the laboratory accreditation program.

Job Accountabilities:

  1. Document management is maintained for all TSANZ controlled documents
  2. Provides a high level of administrative support to the TSANZ Board and CEO
  3. Executive officer assistance to NZ branch to support compliance with NZ legislation and constitution
  4. Undertake administrative support to the laboratory accreditation program:
  • Provide administrative support to subcommittees
  • Regular liaison with the Laboratory Accreditation Coordinator and Subcommittee Chairs to ensure effective overall management of the laboratory accreditation program
  • Check the accreditation applications against TSANZ Laboratory Manual and communicate it back to the laboratories for any major inaccuracy
  • Organise laboratory site visit including date, agenda, travel and accommodation
  • Liaise with assessor panels and laboratories on an ongoing basis to make sure they have the information and support to provide the appropriate application and  assessment
  • Ensure reports/responses from assessor panels and laboratories are received on time, and provided to the CEO and Chair LAC for moderation
  • Maintain accreditation documents including the manual, forms and other templates
  • Maintain accreditation files of each laboratory to reflect best practice in document management
  • Maintain the accredited laboratory information on the TSANZ website
  • Preparation of reports and correspondence     

KEY SELECTION CRITERIA – please address the following in your application:

  • Experience in working in an office environment
  • Must have the ability to communicate accurately and clearly both orally and in writing
  • Pleasant telephone manner
  • Able to think on feet when dealing with callers
  • Customer service oriented with a “can do” approach to work
  • Microsoft Office expertise
  • A team player who is able to work effectively as part of a small productive team and as a self-motivated individual
  • Superior organisational skills, attention to detail and problem solving skills
  • Excellent people skills
  • Experience working in a quality assured environment is advantageous

HOW TO APPLY:

Click apply or send your resume to Tanya.Buchanan@thoracic.org.au by Friday 11th August 2017

Please clearly indicate your relevant experiences and skills to this role.

Position Description: https://www.thoracic.org.au/documents/item/1044

OVERVIEW OF TSANZ: The Thoracic Society of Australia and New Zealand Ltd (TSANZ) is a company limited by guarantee and a health promotion charity (HPC) established to improve the knowledge and understanding of lung disease, to prevent respiratory illness through research and health promotion, and improving health care for people with respiratory disorders.

For details concerning this role, please contact Tanya Buchanan, Phone : 0292226205
Email : tanya.buchanan@thoracic.org.au

You must have the right to live and work in this location to apply for this job.

 

 

 

 

 
 
 
 
 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X